Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern

BACKGROUND: Sequential infections with SARS-CoV-2 variants such as Alpha, Delta, Omicron and its sublineages may cause high morbidity, so it is necessary to develop vaccines that can protect against both wild-type (WT) virus and its variants. Mutations in SARS-CoV-2’s spike protein can easily alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Monika, Su, Shih-Chieh, Liang, Kang-Hao, Lin, Hsiu-Ting, Lu, Yu-Feng, Chen, Kai-Chi, Chen, Wan-Yu, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304269/
https://www.ncbi.nlm.nih.gov/pubmed/37380988
http://dx.doi.org/10.1186/s12929-023-00936-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304269/
https://www.ncbi.nlm.nih.gov/pubmed/37380988
http://dx.doi.org/10.1186/s12929-023-00936-0

Ejemplares similares